Suppr超能文献

组胺(H2)受体拮抗剂对体外纤溶活性的影响。

The effect of histamine (H2) receptor antagonists on the fibrinolytic activity in vitro.

作者信息

Stadnicki A, Kacperek T

出版信息

Thromb Haemost. 1985 Feb 18;53(1):24-5.

PMID:2859669
Abstract

The effect of cimetidine and ranitidine on the fibrinolytic activity in vitro was tested. The inhibition rate of spontaneous lysis rose proportionally to the increasing drug doses. However, a similar effect was obtained with two other drugs of different chemical structures and pharmacological properties. Streptokinase activated fibrinolyse was not affected by either of the drugs at any concentration. Nor was clot formation affected in these experiment conditions. The results of the tests in vitro indicate that inhibition of euglobulin fibrinolysis by H2-receptor antagonists is not specific for these drugs and not connected with their pharmacological properties. It is possible to assume that, during therapeutic use, cimetidine and ranitidine have no antifibrinolytic effect. Possible explanation and relevance of these observations are discussed.

摘要

测试了西咪替丁和雷尼替丁对体外纤溶活性的影响。自发溶解的抑制率随药物剂量增加而成比例上升。然而,另外两种化学结构和药理性质不同的药物也有类似效果。链激酶激活的纤溶不受任何浓度的这两种药物影响。在这些实验条件下凝块形成也未受影响。体外试验结果表明,H2受体拮抗剂对优球蛋白纤溶的抑制并非这些药物所特有,也与它们的药理性质无关。可以推测,在治疗应用中,西咪替丁和雷尼替丁没有抗纤溶作用。讨论了这些观察结果的可能解释及相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验